Suchergebnisse - (Standardsuche:issn:"1568-0096" OR issn:"1873-5576")

PubPharm (640)

21

Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma

enthalten in: Current cancer drug targets | 2022

von Tian, Y. | Lei, Y. | Fu, Y. | +3

22

ND-16 : A Novel Compound for Inhibiting the Growth of Cutaneous T Cell Lymphoma by Targeting JAK2

enthalten in: Current cancer drug targets | 2022

von Zhu, M. | Liu, Y. | Lei, P. | +6

23

β-lapachone : A Promising Anticancer Agent with a Unique NQO1 Specific Apoptosis in Pancreatic Cancer

enthalten in: Current cancer drug targets | 2022

von Qadir, M. | Iqbal, M. | Khan, R.

24

Drug-Induced Peripheral Neuropathy : Diagnosis and Management

enthalten in: Current cancer drug targets | 2022

von Merheb, D. | Dib, G. | Zerdan, M. | +3

25

Experimental Determination of Cancer Drug Targets with Independent Mechanisms of Resistance

enthalten in: Current cancer drug targets | 2022

von Bland, A. | Shrestha, N. | Berry, M. | +2

26

Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy

enthalten in: Current cancer drug targets | 2022

von Taeb, S. | Ashrafizadeh, M. | Zarrabi, A. | +4

27

The Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells

enthalten in: Current cancer drug targets | 2021

von He, Y. | Li, W. | Zhang, J. | +3

28

Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib

enthalten in: Current cancer drug targets | 2021

von Thakur, S. | Ruan, Y. | Jayanthan, A. | +2

29

Management of Prostate Cancer with Systemic Therapy : A Prostate Cancer Unit Perspective

enthalten in: Current cancer drug targets | 2021

von Campodonico, F. | Ennas, M. | Zanardi, S. | +9

30

Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients

enthalten in: Current cancer drug targets | 2021

von Karamat, U. | Ejaz, S.